Eton Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 38.94% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.85%	Opaleye Management Inc.	2,529,887	US$7.9m	4.1%	2.11%
7.72%	Harrow, Inc.	1,982,000	US$6.2m	0%	no data
4.18%	Sean Brynjelsen	1,074,940	US$3.4m	0%	no data
4%	The Vanguard Group, Inc.	1,027,688	US$3.2m	5.25%	no data
2.23%	Westside Investment Management, LLC	573,960	US$1.8m	1.93%	0.48%
1.92%	Acuitas Investments, LLC	492,054	US$1.5m	125%	0.59%
1.17%	Paradigm Capital Management, Inc.	300,000	US$936.0k	0%	0.05%
1.11%	BlackRock, Inc.	284,241	US$886.8k	-0.33%	no data
0.99%	Bridgeway Capital Management, LLC	253,362	US$790.5k	-6.67%	0.01%
0.88%	Geode Capital Management, LLC	227,256	US$709.0k	4.42%	no data
0.78%	Parkman Healthcare Partners LLC	199,168	US$621.4k	20.7%	0.09%
0.63%	Columbia Management Investment Advisers, LLC	161,928	US$505.2k	-13.2%	no data
0.54%	Acadian Asset Management LLC	137,488	US$429.0k	41.4%	no data
0.32%	State Street Global Advisors, Inc.	81,403	US$254.0k	0%	no data
0.31%	BNY Mellon Asset Management	79,402	US$247.7k	0%	no data
0.31%	Essex Investment Management Company, LLC	78,613	US$245.3k	-28.5%	0.05%
0.27%	Charles Casamento	68,420	US$213.5k	0%	no data
0.25%	Northern Trust Global Investments	64,590	US$201.5k	72.2%	no data
0.25%	Squarepoint OPS LLC	63,424	US$197.9k	42.1%	no data
0.23%	Paul Maier	59,745	US$186.4k	0%	no data
0.23%	Norbert Riedel	59,745	US$186.4k	0%	no data
0.23%	Schonfeld Strategic Advisors LLC	58,310	US$181.9k	33.7%	no data
0.2%	Two Sigma Investments, LP	52,500	US$163.8k	-34%	no data
0.2%	Qube Research & Technologies Ltd	50,443	US$157.4k	960%	no data
0.17%	Connor, Clark & Lunn Investment Management Ltd.	43,078	US$134.4k	12.5%	no data